Get the Stockscreener App
0.3905
16.92%
0.0565
After Hours:
.38
-0.0105
-2.69%
Cosmos Health Inc stock is traded at $0.3905, with a volume of 8.74M.
It is up +16.92% in the last 24 hours and up +9.69% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.334
Open:
$0.4162
24h Volume:
8.74M
Relative Volume:
9.39
Market Cap:
$14.58M
Revenue:
$59.79M
Net Income/Loss:
$-18.54M
P/E Ratio:
-0.5509
EPS:
-0.7089
Net Cash Flow:
$-10.45M
1W Performance:
+30.17%
1M Performance:
+9.69%
6M Performance:
-68.76%
1Y Performance:
+12.28%
1-Day Range:
$0.29
$0.45
1-Week Range:
$0.2808
$0.45
52-Week Range:
$0.2801
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3905 | 12.47M | 59.79M | -18.54M | -10.45M | -0.7089 |
MCK
Mckesson Corporation
|
863.42 | 105.68B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
317.58 | 62.23B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
211.83 | 50.58B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
77.42 | 8.86B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.21 | 2.02B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health (COSM) Achieves Record Revenue and Significant Mar - GuruFocus
Cosmos Health reports record revenue of $65.3 million in 2025 By Investing.com - Investing.com South Africa
Cosmos Health gross profit jumped 83% as cash rose tenfold - Stock Titan
Cosmos Health receives third UAE order for 60,000 units - Investing.com
Cosmos Health receives third UAE order for 60,000 units By Investing.com - Investing.com UK
Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units - Palestineherald.com
A third UAE reorder lifts Cosmos Health product demand to 270,000 units - Stock Titan
Cosmos Health reports no material impact from Middle East conflict By Investing.com - Investing.com Australia
Cosmos Health Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView — Track All Markets
Cosmos Health (COSM) Reports Strong Performance Amid Middle East Tensions - GuruFocus
Cosmos Health reports no material impact from Middle East conflict - Investing.com
Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months - Bitget
Iran turmoil missed Cosmos, while its U.S. collagen launch targets $12M - Stock Titan
Market Outlook: Is Cosmos Health Inc part of any major indexEarnings Growth Report & AI Forecasted Stock Moves - baoquankhu1.vn
Cosmos Health plans Q2 U.S. launch of liver supplement Liv18 By Investing.com - Investing.com Australia
COSM Prepares for Q2 U.S. Launch of Liv18, Its Advanced Liver He - GuruFocus
Cosmos Health plans Q2 U.S. launch of liver supplement Liv18 - Investing.com
Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18a Clinically Proven, Patented Supplement for Liver Fat Reduction - ACCESS Newswire
Liver fat affects 30% of U.S. adults. Cosmos plans Q2 Liv18 launch - Stock Titan
Stock Market Recap: Is Cosmos Health Inc stock a good dividend stock2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Cosmos Health Inc (V67A.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
COSM Technical Analysis & Stock Price Forecast - Intellectia AI
Cosmos Health’s C-Scrub Wash 4% passes European testing standard By Investing.com - Investing.com Australia
Cosmos Health’s C-Scrub Wash 4% passes European testing standard - Investing.com
Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets - ACCESS Newswire
Hospital push: Cosmos Health hand wash passes surgical disinfection test - Stock Titan
[NT 10-K] Cosmos Health Inc. SEC Filing - Stock Titan
COSM Should I Buy - Intellectia AI
Can Cosmos Health Inc lead its sector in growthQuarterly Portfolio Review & Weekly Top Gainers Trade List - baoquankhu1.vn
Shorts Report: Is Cosmos Health Inc exposed to currency risks2026 Setups & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
COSM Stock In Spotlight As Company Explores Raising Capital To Address ‘Valuation Disconnect’ - Stocktwits
COSM Earnings History & Surprises | EPS & Revenue Results | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill
Cosmos Health plans guidance update following 2025 results By Investing.com - Investing.com Canada
Aug Drivers: Why is Cosmos Health Inc stock going down2026 Decliners & Expert Verified Movement Alerts - baoquankhu1.vn
COSM Plans to Provide Fresh Operational and Financial Guidance - GuruFocus
Cosmos Health plans guidance update following 2025 results - Investing.com
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Reven - The Manila Times
Cosmos Health Inc. Reports Record Revenue and Strategic U.S. Expansion Plans - quiverquant.com
Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, With Additional $12M+ in High-Margin Reven - 富途牛牛
Cosmos Health purchases $600,000 in Bitcoin for treasury - Investing.com Australia
Cosmos Health (COSM) Buys $600K in Bitcoin, Expands Digital Asset Treasury - Cryptonews.net
Cosmos Health purchases $600,000 in Bitcoin for treasury By Investing.com - Investing.com Canada
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
11.31%
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):